◀ Back to MDM2
MDM2 — PSMD10
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind_translation Interaction:
MDM2
—
PSMD10
(coimmunoprecipitation)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Bind_translation Interaction:
MDM2
—
PSMD10
(affinity chromatography technology)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Biogrid Interaction:
MDM2
—
PSMD10
(direct interaction, pull down)
Qiu et al., Oncogene 2008*
-
IRef Biogrid Interaction:
MDM2
—
PSMD10
(physical association, affinity chromatography technology)
Qiu et al., Oncogene 2008*
-
IRef Biogrid Interaction:
MDM2
—
PSMD10
(physical association, affinity chromatography technology)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Biogrid Interaction:
MDM2
—
PSMD10
(direct interaction, pull down)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Biogrid Interaction:
MDM2
—
PSMD10
(direct interaction, pull down)
Higashitsuji et al., Biochem Biophys Res Commun 2007*
-
IRef Hprd Interaction:
PSMD10
—
MDM2
(in vitro)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Hprd Interaction:
PSMD10
—
MDM2
(in vivo)
Higashitsuji et al., Cancer Cell 2005*
-
IRef Hprd Interaction:
Complex of 36 proteins
(in vivo)
Maguire et al., Cancer Res 2008
-
IRef Hprd Interaction:
Complex of MDM4-MDM2-DHFR-MTBP-PSMD10-RB1
(in vivo)
Maguire et al., Cancer Res 2008
Text-mined interactions from Literome
Higashitsuji et al., Cell cycle (Georgetown, Tex.) 2005
:
Gankyrin increases activities of CDK4 and
MDM2 , and facilitates targeting of polyubiquitylated proteins to the 26S proteasome
Dai et al., J Biol Chem 2006
:
We further show that L11 inhibited
26 S proteasome mediated degradation of ubiquitinated
MDM2 in vitro and consistently prolonged the half-life of MDM2 in cells
Kuo et al., Biochem Pharmacol 2012
(Carcinoma, Hepatocellular...) :
Gankyrin , a positive
regulator of the E3 ubiquitin ligase
MDM2 , was found to be upregulated following HURP expression, and gankyrin knockdown decreased the HURP mediated downregulation of p53